BNP PARIBAS FINANCIAL MARKETS - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.96 and the average weighting 0.5%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$210
-69.3%
140
-79.6%
0.00%
Q4 2022$684
-99.7%
685
+389.3%
0.00%
Q3 2022$252,000
-97.0%
140
-95.2%
0.00%
Q2 2022$8,413,000
-96.8%
2,901
-96.9%
0.00%
Q1 2022$260,806,000
-57.6%
94,495
-28.4%
0.00%
-100.0%
Q4 2021$614,631,000
+822.3%
131,895
+1584.3%
0.00%
Q3 2021$66,642,000
+17.5%
7,831
+126.6%
0.00%
Q2 2021$56,713,000
-89.0%
3,456
-85.1%
0.00%
-100.0%
Q1 2021$513,669,000
+362.3%
23,264
+547.7%
0.00%
Q4 2020$111,101,000
-9.0%
3,592
-40.2%
0.00%
Q3 2020$122,144,000
+1119.6%
6,011
+821.9%
0.00%
Q2 2020$10,015,000
-64.2%
652
-82.0%
0.00%
Q1 2020$27,996,000
-27.7%
3,617
+33.3%
0.00%
Q4 2019$38,742,000
+91.9%
2,713
+102.0%
0.00%
Q3 2019$20,185,000
+1708.7%
1,343
+1621.8%
0.00%
Q2 2019$1,116,000780.00%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
MPM BioImpact LLC 6,741,964$208,528,00018.01%
MPM ASSET MANAGEMENT LLC 4,050,865$125,293,00017.73%
Consonance Capital Management LP 584,885$71,268,0006.66%
SILVERARC CAPITAL MANAGEMENT, LLC 136,000$4,206,0002.44%
Redmile Group, LLC 2,832,888$87,621,0001.06%
Altium Capital Management LP 73,991$2,289,0000.86%
PFM Health Sciences, LP 775,794$23,995,0000.84%
Soleus Capital Management, L.P. 199,867$6,182,0000.82%
MOODY ALDRICH PARTNERS LLC 123,639$3,824,0000.62%
Sofinnova Investments, Inc. 333,707$10,322,0000.61%
View complete list of TCR2 THERAPEUTICS INC shareholders